Why the big drop?, page-22

Gee thanks Barman
Such a defensive intro, what are you so concerned about here? Couldn't even reply to my other post to you.

Considering myself and other posters tried to help you understand the Cymerus tech more recently when you ventured across and were quite ignorant, I find your attitude rather selfish. However, others may have learnt more from reading it, so hope it wasn't wasted.


MSB was mentioned in the interview as well as scaleability/ Gen 1 harvesting vs Gen 2 and GvHD.

I'd like to hear MSB holders comments after listening to it.

Has always been much angst on these threads for years.
I don't expect to be well received here...that will tell me many do think their process to scale cells for future larger targets is old school.

Cynata is the tech enabler, Fuji is your enemy, not CYP...as they may take GvHD market share quickly.
CYP could be a partner for some therapies you are developing.